269.31
前日終値:
$267.67
開ける:
$267.17
24時間の取引高:
408.63K
Relative Volume:
0.56
時価総額:
$22.38B
収益:
$12.71B
当期純損益:
$435.50M
株価収益率:
52.29
EPS:
5.15
ネットキャッシュフロー:
$843.20M
1週間 パフォーマンス:
+2.21%
1か月 パフォーマンス:
+7.89%
6か月 パフォーマンス:
+11.68%
1年 パフォーマンス:
+20.58%
Labcorp Holdings Inc Stock (LH) Company Profile
LH を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
LH
Labcorp Holdings Inc
|
269.31 | 22.24B | 12.71B | 435.50M | 843.20M | 5.15 |
![]()
TMO
Thermo Fisher Scientific Inc
|
477.41 | 174.60B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
205.72 | 143.04B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
652.27 | 52.17B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
117.32 | 32.42B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
185.91 | 30.62B | 15.50B | 1.33B | 2.16B | 7.34 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-07-10 | ダウングレード | HSBC Securities | Buy → Hold |
2025-04-02 | 開始されました | Redburn Atlantic | Buy |
2025-03-04 | アップグレード | Citigroup | Neutral → Buy |
2025-01-07 | アップグレード | Evercore ISI | In-line → Outperform |
2024-12-10 | 再開されました | Jefferies | Buy |
2024-10-30 | アップグレード | HSBC Securities | Hold → Buy |
2024-10-01 | 開始されました | Piper Sandler | Neutral |
2024-03-25 | アップグレード | Argus | Hold → Buy |
2024-02-26 | 開始されました | Leerink Partners | Outperform |
2024-02-09 | 開始されました | Evercore ISI | In-line |
2024-01-03 | 開始されました | Barclays | Equal Weight |
2023-09-06 | 開始されました | HSBC Securities | Hold |
2022-12-12 | ダウングレード | Citigroup | Buy → Neutral |
2022-09-19 | ダウングレード | Argus | Buy → Hold |
2022-08-22 | 再開されました | Morgan Stanley | Overweight |
2022-01-28 | ダウングレード | Deutsche Bank | Buy → Hold |
2021-01-11 | アップグレード | Argus | Hold → Buy |
2021-01-11 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
2021-01-08 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
2020-07-14 | アップグレード | BofA Securities | Neutral → Buy |
2020-07-13 | アップグレード | Wolfe Research | Peer Perform → Outperform |
2020-06-02 | 再開されました | Deutsche Bank | Buy |
2020-05-15 | アップグレード | Mizuho | Neutral → Buy |
2020-04-29 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
2020-04-27 | アップグレード | Citigroup | Neutral → Buy |
2020-04-27 | アップグレード | Wolfe Research | Underperform → Peer Perform |
2020-01-08 | 開始されました | Wells Fargo | Overweight |
2019-07-16 | アップグレード | BofA/Merrill | Underperform → Neutral |
2019-06-21 | アップグレード | Deutsche Bank | Hold → Buy |
2019-04-02 | アップグレード | Jefferies | Hold → Buy |
2019-01-17 | 開始されました | UBS | Buy |
2019-01-03 | ダウングレード | BofA/Merrill | Neutral → Underperform |
2018-12-03 | ダウングレード | Craig Hallum | Buy → Hold |
2018-10-30 | ダウングレード | Argus | Buy → Hold |
2018-10-25 | ダウングレード | Canaccord Genuity | Buy → Hold |
2018-10-19 | 再開されました | BofA/Merrill | Buy |
2018-06-07 | アップグレード | KeyBanc Capital Mkts | Sector Weight → Overweight |
2018-05-01 | アップグレード | Robert W. Baird | Neutral → Outperform |
2018-03-23 | 開始されました | Argus | Buy |
すべてを表示
Labcorp Holdings Inc (LH) 最新ニュース
Labcorp Holdings Sees RS Rating Rise To 73 - Investor's Business Daily
Labcorp Holdings: How Non-GAAP Adjustments Reveal a Stronger Earnings Story and a Potentially Undervalued Stock - AInvest
Investing in Labcorp Holdings (NYSE:LH) Five Years Ago Would Have Delivered You a 71% Gain - 富途牛牛
Analysts Have Conflicting Sentiments on These Healthcare Companies: Labcorp Holdings (LH), Bausch + Lomb Corporation (BLCO) and Radnet (RDNT) - The Globe and Mail
What analysts say about Labcorp Holdings Inc. stock outlookAlpha Focused Technical Trade Signals Gain Attention - beatles.ru
Hero Gum Debuts at New York Mets Game, Providing Fans Opportunity to Sign Up for Gift of Life Marrow Registry - GlobeNewswire Inc.
Is Labcorp Holdings Inc. a growth stock or a value stockDynamic portfolio growth - Jammu Links News
Is it the right time to buy Labcorp Holdings Inc. stockBuild your wealth with consistent stock growth - Jammu Links News
How strong is Labcorp Holdings Inc. company’s balance sheetHigh-yield growth strategies - Jammu Links News
How many analysts rate Labcorp Holdings Inc. as a “Buy”Free Investment Risk Control - Jammu Links News
Does Labcorp Holdings Inc. stock perform well during market downturnsCapitalize on high-yield stock opportunities - Jammu Links News
When is Labcorp Holdings Inc. stock expected to show significant growthHigh-margin investment plays - Jammu Links News
What is the dividend policy of Labcorp Holdings Inc. stockCapitalize on market trends early - Jammu Links News
What makes Labcorp Holdings Inc. stock price move sharplyBuild a diversified portfolio for maximum returns - Jammu Links News
What are Labcorp Holdings Inc. company’s key revenue driversFree Consultation - Jammu Links News
Gilliland, Labcorp director, sells $529k in stock - Investing.com
Gilliland, Labcorp director, sells $529k in stock By Investing.com - Investing.com Canada
LabCorp Holdings Director Gilliland Dwight Gary Sells 2000 Shares at $264.95/Share. - AInvest
Can a trend reversal in Labcorp Holdings Inc. lead to recoveryMomentum Based Equity Trading Plans Reviewed - metal.it
Labcorp Holdings (LH) Unveils Test Finder: AI Tool for Streamlined Lab Test Selection - Yahoo Finance
Labcorp Holdings: Top Momentum Stock for Long-Term Investors - AInvest
Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Advanced analytics toolkit walkthrough for Labcorp Holdings Inc.Buy Low Sell High Stock Watch Strategy in Focus - metal.it
The 5 Most Interesting Analyst Questions From Labcorp’s Q2 Earnings Call - Yahoo Finance
Labcorp Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72 - simplywall.st
Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search - MarketScreener
Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic - Yahoo Finance
Price Consolidation Hints at Upcoming Move in Labcorp Holdings Inc.Profit Focused Stock Screener Results Released - metal.it
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term - Yahoo Finance
Quest, Labcorp downplay ‘Big Beautiful Bill’ impact - Yahoo Finance
Breakthrough Cancer Test Gets EU Approval: New Hope for 2.7M European Cancer Patients Annually - Stock Titan
Should I hold or sell Labcorp Holdings Inc. stock in 2025Best Dividend Outlook For Consistent Profits - jammulinksnews.com
Labcorp’s SWOT analysis: diagnostics giant’s stock faces valuation scrutiny By Investing.com - Investing.com Nigeria
Labcorp’s SWOT analysis: diagnostics giant’s stock faces valuation scrutiny - Investing.com Australia
Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE - FinancialContent
Gift of Life in Collaboration with Labcorp and DOUBLEMINT®, Launch Hero Gum to Expand Marrow Donor Registry - Yahoo Finance
How Efficient Is Labcorp Holdings Inc. at Controlling Operating CostsCapital Safe Stock Watchlist - metal.it
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MSN
What is the risk reward ratio of investing in Labcorp Holdings Inc. stockCapitalize on strong market momentum - Jammu Links News
How does Labcorp Holdings Inc. generate profit in a changing economyFree Risk Assessment Services - Jammu Links News
Labcorp Holdings Inc (LH) 財務データ
収益
当期純利益
現金流量
EPS
Labcorp Holdings Inc (LH) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Gilliland Dwight Gary | Director |
Jul 30 '25 |
Sale |
264.95 |
2,000 |
529,900 |
6,656 |
Wilkinson Peter J | SVP, Chief Accounting Officer |
Jul 29 '25 |
Sale |
261.02 |
202 |
52,727 |
1,852 |
大文字化:
|
ボリューム (24 時間):